ARS Pharma to Report Third Quarter 2026 Financial Results

Go back to ARS Pharma to Report Third Quarter 2026 Financial Results
(NASDAQ: SPRY) Delayed: 3.05 --0 (-0%)
Previous Close $3.05    52 Week High $ 
Open $3.13    52 Week Low $ 
Day High $3.23    P/E N/A 
Day Low $3.00    EPS $ 
Volume 2,494,296